Search results for “Neprilysin” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 659 patents, we discovered top 46 key players by total patent application. Theravance Biopharma R&D IP LLC, Novartis AG, Innoviva, Inc. are dominant in this area. They take 74.20% of the total patent filing.
Theravance Biopharma R&D IP LLC
California, United States
Patent: 360
Novartis AG
Basel-Stadt, Switzerland
Patent: 67
Innoviva, Inc.
California, United States
Patent: 62
Astute Medical, Inc.
California, United States
Patent: 16
Pharmaleads SA
France
Patent: 16
Suzhou Jingyun Pharmaceutical Technology Co. Ltd.
Jiangsu Sheng, China
Patent: 15
Suzhou Pengxu Pharmatech Co.,Ltd
Jiangsu Sheng, China
Patent: 15
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 13
MEDIPOST Co., Ltd.
Gyeonggi-do, South Korea
Patent: 12
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 8
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 80 patents applied in the last 5 years. We discover 25 most active companies in this area. The fast-growing Theravance Biopharma R&D IP LLC, Pharmaleads SA, Designed Cells Co. Ltd. take 50.00% of patent filing during this period.
Theravance Biopharma R&D IP LLC
California, United States
Patent: 26
Pharmaleads SA
France
Patent: 9
Designed Cells Co. Ltd.
South Korea
Patent: 5
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Guangdong Sheng, China
Patent: 3
Oxford University Innovation Ltd.
United Kingdom
Patent: 2
Boryung Corp.
South Korea
Patent: 2
Ache Laboratorios Farmaceuticos S.A.
São Paulo, Brazil
Patent: 2
Novartis AG
Basel-Stadt, Switzerland
Patent: 2
J2H Biotech, Inc.
Gyeonggi-do, South Korea
Patent: 2
Codiak BioSciences, Inc.
California, United States
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 80 patents in last 5 years, we discover 15 new entrants. Designed Cells Co. Ltd., J2H Biotech, Inc., Oxford University Innovation Ltd. are the most active new entrants in this area.
Designed Cells Co. Ltd.
South Korea
Patent: 5
J2H Biotech, Inc.
Gyeonggi-do, South Korea
Patent: 2
Oxford University Innovation Ltd.
United Kingdom
Patent: 2
Boryung Corp.
South Korea
Patent: 2
Codiak BioSciences, Inc.
California, United States
Patent: 2
Ache Laboratorios Farmaceuticos S.A.
São Paulo, Brazil
Patent: 2
Monash University
Victoria, Australia
Patent: 1
Pfizer Inc.
New York, United States
Patent: 1
Tianjin University
Tianjin Shi, China
Patent: 1
Hytest Oy
Finland
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 51 patents, we discovered top 10 universities and scientific research institutions by total patent application. Academia Sinica, University of Zurich, The Johns Hopkins University are dominant in this area. They take 33.33% of the total patent filing.
Academia Sinica
China
Patent: 6
University of Zurich
ZURICH, Switzerland
Patent: 4
The Johns Hopkins University
United States
Patent: 2
Regents of the University of Colorado
Colorado, United States
Patent: 2
University of South Florida
United States
Patent: 1
The University of Queensland
Queensland, Australia
Patent: 1
Monash University
Victoria, Australia
Patent: 1
University of Nagasaki
Chiba-ken, Japan
Patent: 1
Qingdao University
Shandong Sheng, China
Patent: 1
Tianjin University
Tianjin Shi, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: